Status:
COMPLETED
An Iliopsoas Plane Block After Total Hip Arthroplasty
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Total Hip Arthroplasty
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Nielsen et al. reported that when iliopsoas plane block was performed on healthy volunteers, the injection solution in Hip MRI was confined to the myofascial compartment, which was known to include al...
Eligibility Criteria
Inclusion
- Patients 19 years of age or older who are expected to undergo unilateral hip arthroplasty
- ASA PS 1-3
Exclusion
- Revision total hip arthroplasty
- Allergy to drugs used in the study
- Patients with moderate or more hepatic impairment (AST/ALT is more than 2.5 times the upper limit of normal)
- Estimated glomerular filtration rate \< 30 mL/min/1.73m2
- Opioid dependence
- Prolongation of PT and aPTT more than twice the upper limit of normal
- Pre-existing neurological or anatomical disorders of the lower extremities
- Serious psychiatric disorders
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 5 2023
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05212038
Start Date
February 15 2022
End Date
January 5 2023
Last Update
February 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ji Yeong Kim
Seoul, South Korea